BioSpace News Archive

Merck, known as MSD outside the United States and Canada, announced that the Board of Directors has declared a quarterly dividend of $0.55 per share of the company’s common stock for the second quarter of 2019.

Pelican BioThermal, the global name in temperature controlled packaging, announces the opening of a new network station and service center in Los Angeles to service, refurbish, repair and condition Pelican BioThermal’s reusable Crēdo on Demand shippers

ANGLE plc (AIM:AGL OTCQX:ANPCY), a world-leading liquid biopsy company, is delighted to announce that its ParsortixTM system has been successfully used to improve the workflows and sensitivity of lymph node analysis in melanoma

Shield Therapeutics plc (LSE: STX) a commercial stage, pharmaceutical company with an initial focus on addressing iron deficiency, announces positive results from the open-label extension phase of the AEGIS-CKD pivotal study of Feraccru®, a novel oral ferric iron therapy that is approved and marketed in the European Union for the treatment of iron deficiency (ID) in adults and in Switzerland for the treatment of iron deficiency anaemia (IDA) in adults with inflammatory bowel disease

Amgen announced financial results for the fourth quarter and full year 2018 in comparison to comparable periods in 2017.

NuVasive, Inc. announced the Company will release its fourth quarter and full year 2018 earnings results on Wednesday, Feb. 20, 2019 after the close of the market.

Array BioPharma, Inc. will report financial results for the second quarter of fiscal 2019 and hold a conference call to discuss those results on Tuesday, February 5, 2019.

Endologix, Inc., a developer and marketer of innovative treatments for aortic disorders, announced that it will report financial results for the fourth quarter and fiscal year 2018 after the market close on Monday, February 25, 2019.

Conference Call and Webcast to Follow at 5:00 p.m. EST/ 2:00 p.m. PST

PolarityTE, Inc. announced that David Seaburg will join the Company in the newly-created role of President of Corporate Development.